New York State Common Retirement Fund
BCLI

New York State Common Retirement Fund’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

New York State Common Retirement Fund’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18
Closed -$1K – 3345
2021
Q2 		$1K Sell
18
-982
-98% -$52.5K ﹤0.01% 3365
2021
Q1 		$57K Buy
1,000
+620
+163% +$46.8K ﹤0.01% 3187
2020
Q4 		$26K Sell
380
-1,253
-77% -$171K ﹤0.01% 3240
2020
Q3 		$415K Hold
1,633
– – ﹤0.01% 2296
2020
Q2 		$275K Buy
+1,633
New +$176K ﹤0.01% 2504

Other funds holding BCLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AHB
Abner Herrman & Brock Jersey City, New Jersey $1.05B AUM 42.66% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

New York State Common Retirement Fund's BCLI Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q3 2021, closing a stake of 18 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in BCLI in Q2 2020 and held it in 5 quarters. The position peaked at $415K in Q3 2020. 52 funds tracked by Wall St. Rank hold BCLI as of Q3 2021.

  • New York State Common Retirement Fund reported no remaining BRAINSTORM CELL THERAPUTC position as of Q3 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 18 BRAINSTORM CELL THERAPUTC shares in Q3 2021, an estimated $1K.
  • New York State Common Retirement Fund first reported a position in BRAINSTORM CELL THERAPUTC in Q2 2020 and held it in 5 quarters.
  • New York State Common Retirement Fund's BRAINSTORM CELL THERAPUTC position peaked at $415K in Q3 2020.
  • 52 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.